Prostate specific antigen negative prostate cancer
Prostate specific antigen (PSA) has been used in the diagnosis and monitoring of prostate cancer for almost 20 years. Most men who present with metastatic prostate cancer have markedly elevated serum levels of PSA. However, approximately 1% of cases have serum PSA levels that are much lower than the...
Main Author: | Birtle, A. J. |
---|---|
Published: |
University College London (University of London)
2005
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.634555 |
Similar Items
-
The identification of prostate cancer associated tumour antigens and biomarkers
by: Dede, A. Y.
Published: (2015) -
Expression, regulation and roles of semaphorins and their receptors in prostate and prostate cancer
by: Blanc, Véronique Maxence
Published: (2008) -
A study of the endogenous negative signalling regulator Similar Expression to FGF (Sef) in prostate cancer
by: Hori, Satoshi
Published: (2015) -
Prognostic indicators in prostate cancer
by: Oxley, Jonathan David
Published: (2001) -
The role of diet and lifestyle in prostate cancer
by: Er, Vanessa
Published: (2015)